{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T13:40:45Z","timestamp":1713706845509},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,21]]},"DOI":"10.7759\/cureus.58682","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T13:24:03Z","timestamp":1713705843000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Clinical Characteristics and Biomarkers in Culture-Positive and Culture-Negative Sepsis Patients"],"prefix":"10.7759","author":[{"given":"Pawan K","family":"Goyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd KE","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al.. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020, 395:200-11. 10.1016\/S0140-6736(19)32989-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201310-1875OC","article-title":"Association between source of infection and hospital mortality in patients who have septic shock","volume":"189","author":"Leligdowicz A","year":"2014","unstructured":"Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014, 189:1204-13. 10.1164\/rccm.201310-1875OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek C","year":"2020","unstructured":"Fleischmann-Struzek C, Mellhammar L, Rose N, et al.. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020, 46:1552-62. 10.1007\/s00134-020-06151-x","journal-title":"Intensive Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2017.278","article-title":"Sepsis 2018: Definitions and guideline changes","volume":"19","author":"Napolitano LM","year":"2018","unstructured":"Napolitano LM. Sepsis 2018: Definitions and guideline changes. Surg Infect (Larchmt). 2018, 19:117-25. 10.1089\/sur.2017.278","journal-title":"Surg Infect (Larchmt)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05862-w","article-title":"Comparing mortality between positive and negative blood culture results: an inverse probability of treatment weighting analysis of a multicenter cohort","volume":"21","author":"Liu A","year":"2021","unstructured":"Liu A, Yo CH, Nie L, et al.. Comparing mortality between positive and negative blood culture results: an inverse probability of treatment weighting analysis of a multicenter cohort. BMC Infect Dis. 2021, 21:182. 10.1186\/s12879-021-05862-w","journal-title":"BMC Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170149","article-title":"Clinical implications of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"190","author":"Fernando SM","year":"2018","unstructured":"Fernando SM, Rochwerg B, Seely AJ. Clinical implications of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). CMAJ. 2018, 190:E1058-9. 10.1503\/cmaj.170149","journal-title":"CMAJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S334161","article-title":"Comparison of clinical characteristics and outcomes between positive and negative blood culture septic patients: a retrospective cohort study","volume":"14","author":"Yang L","year":"2021","unstructured":"Yang L, Lin Y, Wang J, et al.. Comparison of clinical characteristics and outcomes between positive and negative blood culture septic patients: a retrospective cohort study. Infect Drug Resist. 2021, 14:4191-205. 10.2147\/IDR.S334161","journal-title":"Infect Drug Resist"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03421-4","article-title":"Characteristics and clinical outcomes of culture-negative and culture-positive septic shock: a single-center retrospective cohort study","volume":"25","author":"Kim JS","year":"2021","unstructured":"Kim JS, Kim YJ, Kim WY. Characteristics and clinical outcomes of culture-negative and culture-positive septic shock: a single-center retrospective cohort study. Crit Care. 2021, 25:11. 10.1186\/s13054-020-03421-4","journal-title":"Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02993-5","article-title":"Biomarkers of sepsis: time for a reappraisal","volume":"24","author":"Pierrakos C","year":"2020","unstructured":"Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020, 24:287. 10.1186\/s13054-020-02993-5","journal-title":"Crit Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2021.103289","article-title":"Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or \"just\" a marker of bacterial coinfection?","volume":"69","author":"Lugito NP","year":"2021","unstructured":"Lugito NP. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or \"just\" a marker of bacterial coinfection?. Curr Res Transl Med. 2021, 69:103289. 10.1016\/j.retram.2021.103289","journal-title":"Curr Res Transl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206527","article-title":"The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics","volume":"13","author":"Yunus I","year":"2018","unstructured":"Yunus I, Fasih A, Wang Y. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One. 2018, 13:e0206527. 10.1371\/journal.pone.0206527","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-016-1457-z","article-title":"Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria","volume":"186","author":"Liu HH","year":"2017","unstructured":"Liu HH, Zhang MW, Guo JB, Li J, Su L. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria. Ir J Med Sci. 2017, 186:207-12. 10.1007\/s11845-016-1457-z","journal-title":"Ir J Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518822404","article-title":"Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock: retrospective analysis of 59 cases","volume":"47","author":"Cui N","year":"2019","unstructured":"Cui N, Zhang H, Chen Z, Yu Z. Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock: retrospective analysis of 59 cases. J Int Med Res. 2019, 47:1573-9. 10.1177\/0300060518822404","journal-title":"J Int Med Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000958","article-title":"Lactate and immunosuppression in sepsis","volume":"49","author":"Nolt B","year":"2018","unstructured":"Nolt B, Tu F, Wang X, Ha T, Winter R, Williams DL, Li C. Lactate and immunosuppression in sepsis. Shock. 2018, 49:120-5. 10.1097\/SHK.0000000000000958","journal-title":"Shock"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4997\/JRCPE.2019.308","article-title":"Biomarkers and newer laboratory investigations in the diagnosis of sepsis","volume":"49","author":"Raveendran AV","year":"2019","unstructured":"Raveendran AV, Kumar A, Gangadharan S. Biomarkers and newer laboratory investigations in the diagnosis of sepsis. J R Coll Physicians Edinb. 2019, 49:207-16. 10.4997\/JRCPE.2019.308","journal-title":"J R Coll Physicians Edinb"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/japtr.JAPTR_319_18","article-title":"Comparison of serum procalcitonin level with erythrocytes sedimentation rate, C-reactive protein, white blood cell count, and blood culture in the diagnosis of bacterial infections in patients hospitalized in Motahhari hospital of Urmia (2016)","volume":"9","author":"Nasimfar A","year":"2018","unstructured":"Nasimfar A, Sadeghi E, Karamyyar M, Manesh LJ. Comparison of serum procalcitonin level with erythrocytes sedimentation rate, C-reactive protein, white blood cell count, and blood culture in the diagnosis of bacterial infections in patients hospitalized in Motahhari hospital of Urmia (2016). J Adv Pharm Technol Res. 2018, 9:147-52. 10.4103\/japtr.JAPTR_319_18","journal-title":"J Adv Pharm Technol Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","unstructured":"Biomarkers and surrogate endpoints. preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001, 69:89-95. 10.1067\/mcp.2001.113989","journal-title":"Clin Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181a02afc","article-title":"Biomarkers of sepsis","volume":"37","author":"Marshall JC","year":"2009","unstructured":"Marshall JC, Reinhart K. Biomarkers of sepsis. Crit Care Med. 2009, 37:2290-8. 10.1097\/CCM.0b013e3181a02afc","journal-title":"Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03592-8","article-title":"Comparison of culture-negative and culture-positive sepsis or septic shock: a systematic review and meta-analysis","volume":"25","author":"Li Y","year":"2021","unstructured":"Li Y, Guo J, Yang H, Li H, Shen Y, Zhang D. Comparison of culture-negative and culture-positive sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2021, 25:167. 10.1186\/s13054-021-03592-8","journal-title":"Crit Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000004072","article-title":"Culture-negative and culture-positive sepsis: a comparison of characteristics and outcomes","volume":"129","author":"Sigakis MJ","year":"2019","unstructured":"Sigakis MJ, Jewell E, Maile MD, Cinti SK, Bateman BT, Engoren M. Culture-negative and culture-positive sepsis: a comparison of characteristics and outcomes. Anesth Analg. 2019, 129:1300-9. 10.1213\/ANE.0000000000004072","journal-title":"Anesth Analg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02147","article-title":"Epidemiology and immune pathogenesis of viral sepsis","volume":"9","author":"Lin GL","year":"2018","unstructured":"Lin GL, McGinley JP, Drysdale SB, Pollard AJ. Epidemiology and immune pathogenesis of viral sepsis. Front Immunol. 2018, 9:2147. 10.3389\/fimmu.2018.02147","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4161\/viru.26187","article-title":"Invasive candidiasis as a cause of sepsis in the critically ill patient","volume":"5","author":"Delaloye J","year":"2014","unstructured":"Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014, 5:161-9. 10.4161\/viru.26187","journal-title":"Virulence"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone RC","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, et al.. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992, 101:1644-55. 10.1378\/chest.101.6.1644","journal-title":"Chest"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S415200","article-title":"Detection of inflammatory biomarkers among patients with sepsis of gram-negative bacteria: a cross-sectional study","volume":"16","author":"Khana TQ","year":"2023","unstructured":"Khana TQ, Anwar KA. Detection of inflammatory biomarkers among patients with sepsis of gram-negative bacteria: a cross-sectional study. Int J Gen Med. 2023, 16:3963-76. 10.2147\/IJGM.S415200","journal-title":"Int J Gen Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/cc12896","article-title":"Characteristics and outcomes of culture-negative versus culture-positive severe sepsis","volume":"17","author":"Phua J","year":"2013","unstructured":"Phua J, Ngerng W, See K, et al.. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013, 17:R202. 10.1186\/cc12896","journal-title":"Crit Care"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000004042","article-title":"Editorial by US Food and Drug Administration attorney fails to address core and ongoing issues seen with vasopressin market","volume":"128","author":"Almeter PJ","year":"2019","unstructured":"Almeter PJ, Hessel EA 2nd, Labuhn JA, Morris PE. Editorial by US Food and Drug Administration attorney fails to address core and ongoing issues seen with vasopressin market. Anesth Analg. 2019, 128:e55-6. 10.1213\/ANE.0000000000004042","journal-title":"Anesth Analg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/242106-comparison-of-clinical-characteristics-and-biomarkers-in-culture-positive-and-culture-negative-sepsis-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T13:24:07Z","timestamp":1713705847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/242106-comparison-of-clinical-characteristics-and-biomarkers-in-culture-positive-and-culture-negative-sepsis-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,21]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.58682","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,21]]}}}